Cartagenia logo

Cartagenia

1 employees · est. 2008 · Leuven, Belgium

VS
Scribe Therapeutics logo

Scribe Therapeutics

CRISPR by Design™

87 employees · est. 2017 · Alameda, United States

Cartagenia is the older company (2008 vs 2017); Scribe Therapeutics is the larger of the two.

Side-by-Side Comparison

Cartagenia Scribe Therapeutics
Founded
2008 older 2017
Headquarters
Leuven, Belgium Alameda, United States
Employees
1 87 larger
Industry
Not tracked yet Biotechnology
Funding Stage
Series Unknown Series B
Total Funding
$6.45M $140.00M
Funding Rounds
2 5
Services
Not tracked yet CRISPR genetic engineering, therapeutic development, preclinical data research, strategic partnerships
Target Customers
Not tracked yet individuals with genetic predispositions, patients with cardiometabolic diseases, pharmaceutical companies, medical researchers
Taxonomy
Genetic Analysis, Diagnostic Knowledge, Software Systems, Database Systems, Clinical Genetics, Genetic Interpretation, Counseling Services Genetic Medicines, CRISPR Technology, Gene Editing, Genetic Modification, Precision Medicine, Life Sciences, Biopharmaceuticals, Genomic Innovation, Therapeutic Development, Genome Engineering, Molecular Biology, Medical Biotechnology
Website
cartagenia.com scribetx.com
Cartagenia logo

About Cartagenia

Cartagenia is a Belgian startup founded in 2008, specializing in delivering diagnostic knowledge, software, and database systems focused on enabling genetic labs and clinicians to conduct clinically relevant genetic analyses efficiently. The company aims to facilitate high-quality genetic interpreta...

Scribe Therapeutics logo

About Scribe Therapeutics

Scribe Therapeutics, founded in 2017, is a cutting-edge player in the Biotechnology sector. With the motto "CRISPR by Design™," the company focuses on creating genetic medicines through an innovative approach to genetic modification. The firm is headquartered in the United States and seeks to revol...

We will tell you when either one moves

BounceWatch watches Cartagenia and Scribe Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Cartagenia and Scribe Therapeutics — by email.

Frequently Asked Questions

Cartagenia. Scribe Therapeutics — CRISPR by Design™. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Cartagenia has raised $6.45M while Scribe Therapeutics has raised $140.00M.
Cartagenia and Scribe Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Cartagenia with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Cartagenia on 11 Sep 2024, and Scribe Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes